| 宝积资本 |
JASON CHAN WA CHIANG |
增持 |
100000000 |
10000.00万股 |
0.10% |
好仓 |
2022-11-21 |
| 南戈壁 |
安勇 |
增持 |
37565569 |
27514.49万股 |
0.93% |
好仓 |
2022-11-19 |
| 南戈壁 |
JD Zhixing Fund L.P. |
增持 |
37565569 |
27514.49万股 |
0.93% |
好仓 |
2022-11-19 |
| 南戈壁 |
JD Dingxing Limited |
增持 |
37565569 |
27514.49万股 |
0.93% |
好仓 |
2022-11-19 |
| 南戈壁 |
Inner Mongolia Tianyu Trading Limited |
增持 |
37565569 |
27514.49万股 |
0.93% |
好仓 |
2022-11-19 |
| 南戈壁 |
朱重临 |
增持 |
37565569 |
27514.49万股 |
0.93% |
好仓 |
2022-11-19 |
| 汇财金融投资 |
田一妤 |
增持 |
3330000 |
3659.30万股 |
0.29% |
好仓 |
2022-11-18 |
| 微泰医疗-B |
施毅 |
减持 |
-8545840 |
1709.17万股 |
0.39% |
好仓 |
2022-11-18 |
| 微泰医疗-B |
施毅 |
增持 |
8545840 |
1246.45万股 |
0.07% |
好仓 |
2022-11-18 |
| 微泰医疗-B |
LAV Corporate GP, Ltd. |
增持 |
8545840 |
854.58万股 |
0.05% |
好仓 |
2022-11-18 |
| 微泰医疗-B |
LAV Evergreen (Hong Kong) Co., Limited |
增持 |
8545840 |
854.58万股 |
0.05% |
好仓 |
2022-11-18 |
| 微泰医疗-B |
LAV Evergreen (Hong Kong) Co., Limited |
减持 |
-8545840 |
1709.17万股 |
0.39% |
好仓 |
2022-11-18 |
| 微泰医疗-B |
LAV Corporate GP, Ltd. |
减持 |
-8545840 |
1709.17万股 |
0.39% |
好仓 |
2022-11-18 |
| 微泰医疗-B |
Lilly Asia Ventures Fund GP, L.P. |
减持 |
-8545840 |
1709.17万股 |
0.39% |
好仓 |
2022-11-18 |
| 微泰医疗-B |
Lilly Asia Ventures Fund GP, L.P. |
增持 |
8545840 |
854.58万股 |
0.05% |
好仓 |
2022-11-18 |
| 微泰医疗-B |
Lilly Asia Ventures Fund II, L.P. |
增持 |
8545840 |
854.58万股 |
0.05% |
好仓 |
2022-11-18 |
| 微泰医疗-B |
Lilly Asia Ventures Fund II, L.P. |
减持 |
-8545840 |
1709.17万股 |
0.39% |
好仓 |
2022-11-18 |
| 赛生药业 |
朱伟航 |
减持 |
-35734000 |
625.38万股 |
0.01% |
好仓 |
2022-11-18 |
| 赛生药业 |
Boying Investments Limited |
减持 |
-35734000 |
625.38万股 |
0.01% |
好仓 |
2022-11-18 |
| 赛生药业 |
Great Origin Ventures Limited |
减持 |
-35734000 |
625.38万股 |
0.01% |
好仓 |
2022-11-18 |
